Tuoxin Pharmaceutical: Plans to raise no more than 228 million yuan through private placement.

Tuoxin Pharmaceutical announced that it plans to issue A shares to specific targets to raise funds of up to 228 million yuan. The net amount of funds raised, after deducting issuance expenses, will be used entirely for the construction of the biomanufacturing base for raw materials and health food supplements. The number of shares to be issued this time will not exceed 37.9634 million shares, and the final issuance price will be determined in accordance with relevant laws and regulations and regulatory requirements. This issuance still requires approval from the company's shareholders' meeting, approval from the Shenzhen Stock Exchange, and registration approval from the China Securities Regulatory Commission before it can be implemented.